Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis

NCT03122353 is registered in ClinicalTrials.gov with Tolmar Inc. as lead sponsor.

NCT NCT03122353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03122353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis
Lead sponsor
Tolmar Inc.
Phase
Phase 1
Overall status
Completed
Start date
April 11, 2017
Completion date
November 15, 2017
Enrollment
699 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

scalp psoriasis